Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) ...

A University of Minnesota Medical School research team has examined the financial burden of different medical services—including outpatient care, inpatient care, prescription drugs and physical ...

The machines, which cost six figures and are used during heart surgery, will now have to be repaired by the company directly.